{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:51:32Z","timestamp":1791323492142,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.pnpbp.2010.08.009","type":"journal-article","created":{"date-parts":[[2010,8,21]],"date-time":"2010-08-21T05:11:02Z","timestamp":1282367462000},"page":"1484-1490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients"],"prefix":"10.1016","volume":"34","author":[{"given":"Arun K.","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarlath B.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Likhodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.08.009_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/appi.ps.54.4.565","article-title":"The impact of weight gain on quality of life among persons with schizophrenia","volume":"54","author":"Allison","year":"2003","journal-title":"Psychiatr Serv"},{"issue":"Suppl 23","key":"10.1016\/j.pnpbp.2010.08.009_bb0010","first-page":"13","article-title":"Epidemiology, morbidity, and treatment of overweight and obesity","volume":"62","author":"Aronne","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0196-9781(81)80123-4","article-title":"Regional distributions of somatostatin and cholecystokinin-like immunoreactivities in rat and bovine brain","volume":"2","author":"Barden","year":"1981","journal-title":"Peptides"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0025","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(02)11706-5","article-title":"759C\/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain","volume":"360","author":"Basile","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(81)90031-7","article-title":"The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay","volume":"212","author":"Beinfeld","year":"1981","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.mp.4000293","article-title":"Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder","volume":"3","author":"Bowen","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0016-5085(76)80490-8","article-title":"Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa","volume":"70","author":"Buffa","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MED.0b013e3280122850","article-title":"Cholecystokinin","volume":"14","author":"Chandra","year":"2007","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.177.1.4","article-title":"Stigmatisation of people with mental illnesses","volume":"177","author":"Crisp","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1461145707007547","article-title":"Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis","volume":"10","author":"De Luca","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gepi.10252","article-title":"Pedigree disequilibrium tests for multilocus haplotypes","volume":"25","author":"Dudbridge","year":"2003","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00014.2005","article-title":"Cholecystokinin and gastrin receptors","volume":"86","author":"Dufresne","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajmg.b.20169","article-title":"Weight gain associated with the \u2212759C\/T polymorphism of the 5HT2C receptor and olanzapine","volume":"134B","author":"Ellingrod","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0075","author":"Gauderman"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/245323a0","article-title":"Cholecystokinin elicits satiety in rats with open gastric fistulas","volume":"245","author":"Gibbs","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0085","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2008.40","article-title":"Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway","volume":"13","author":"Girgis","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.mp.4000788","article-title":"No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder","volume":"6","author":"Hamilton","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.mp.4000875","article-title":"Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia","volume":"6","author":"Hattori","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-7091-0579-5_17","article-title":"Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder","author":"Hosing","year":"2004","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.65.7.841","article-title":"The incentive salience of alcohol: translating the effects of genetic variant in CNR1","volume":"65","author":"Hutchison","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.mp.4000507","article-title":"Investigation of cholecystokinin system genes in panic disorder","volume":"4","author":"Kennedy","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ajcn\/34.2.154","article-title":"C-terminal octapeptide of cholecystokinin decreases food intake in man","volume":"34","author":"Kissileff","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI4901","article-title":"The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight","volume":"103","author":"Kopin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0125","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0130","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/512133","article-title":"No gene is an island: the flip-flop phenomenon","volume":"80","author":"Lin","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0893-133X(98)00007-4","article-title":"Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients","volume":"19","author":"Masellis","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0145","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0091-3057(92)90435-I","article-title":"Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats","volume":"43","author":"Melville","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.b.30115","article-title":"Clozapine-induced weight gain associated with the 5HT2C receptor \u2212759C\/T polymorphism","volume":"133B","author":"Miller","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0155","first-page":"R618","article-title":"Disordered food intake and obesity in rats lacking cholecystokinin A receptors","volume":"274","author":"Moran","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/14622416.7.6.863","article-title":"Genetics of antipsychotic treatment emergent weight gain in schizophrenia","volume":"7","author":"M\u00fcller","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.euroneuro.2005.02.001","article-title":"Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia","volume":"15","author":"M\u00fcller","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.12.037","article-title":"The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia","volume":"379","author":"M\u00fcller","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2009.06.005","article-title":"Gut hormones: implications for the treatment of obesity","volume":"124","author":"Neary","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0185","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pnpbp.2005.03.019","article-title":"The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment","volume":"29","author":"Reynolds","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<700::AID-AJMG21>3.0.CO;2-X","article-title":"Novel polymorphism in the promoter and coding regions of the human cholecystokinin B receptor gene: an association analysis with schizophrenia","volume":"88","author":"Tachikawa","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01213011-200504000-00002","article-title":"Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis","volume":"15","author":"Templeman","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/npp.2009.235","article-title":"A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia","volume":"35","author":"Tiwari","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/hup.1111","article-title":"Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients","volume":"25","author":"Tiwari","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"159","author":"Volavka","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0215","first-page":"G628","article-title":"Cholecystokinin receptors","volume":"269","author":"Wank","year":"1995","journal-title":"Am J Physiol"},{"issue":"Suppl 18","key":"10.1016\/j.pnpbp.2010.08.009_bb0220","first-page":"13","article-title":"Schizophrenia and obesity: impact of antipsychotic medications","volume":"65","author":"Wirshing","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajhg.2008.02.001","article-title":"Genetic flip-flop without an accompanying change in linkage disequilibrium","volume":"82","author":"Zaykin","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2010.08.009_bb0230","first-page":"2119","article-title":"Association of \u22122548G\/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain","volume":"83","author":"Zhang","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461000312X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461000312X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:11:55Z","timestamp":1791321115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461000312X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S027858461000312X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.08.009","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}